Effect of CYP1A2, CYP2D6, and CYP3A4 Variation on Antipsychotic Treatment Outcomes
No Thumbnail Available
Issue Date
2025
Our author(s)
Blake, H.
Department
Keywords
Genetics , Pharmacology , Psychosis
Language
en
Publisher
MDPI
ISSN
eISSN
1424-8247
ISBN
Type
article
Citation
Varney, L., Murtough, S., Cotic, M., Abidoph, R., Chan, L., Khani, N.S., Richards-Belle, A., Richards-Brown, M., Mills, D., Panconesi, D., Dawda, Y., Sharma, P., Shah, c., Secchi, A., Nilforooshan, R., Mudholkar, S., Murdoch, R., Molai, J., Griffiths, R., Senthilkumar, S., Blake, H., Lankshear, S., McRoberts, J., Pastor, B., Thomas, C., Richards, S., Welfare-Wilson, A., Cheung, S., Cox, R., Jibero, A.C., Anad, R., Laczik, R., Ghali, S., Berry, A.J., Curwen, J., Odutoye, K., Kottalgi, G., Williams, S., Wong, S., Anandan, N., Pius, G., Ajiteru, T., Clark, V., van Driel, P., Bashir, A., Court, S., Pawsey, M., Skowronska, A., Woodley, J. & Bramon, E. 2025. Pharmaceuticals, 18, (6), 892.